Status and phase
Conditions
Treatments
About
Primarily, this clinical investigation compared overall survival and recurrence-free survival in patients with hormone receptor-negative breast cancer treated with pre- and postoperative chemotherapy vs. conventional postoperative treatment.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients with bioptically verified breast cancer
Estrogen receptor-negative status
Age: < 70 years
WHO Performance Status < 2
Laboratory parameters
</= 4 weeks interval since surgery
Informed consent
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
429 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal